LEEN VIEW SURGERY
BULWELL RIVERSIDE CENTRE, MAIN STREET, BULWELL, NOTTINGHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 13 | 69.2% | |
| HF 4 | 2011 | 11 | 14 | 78.6% | |
| HF 4 | 2012 | 14 | 16 | 87.5% | |
| HF 4 | 2013 | 15 | 17 | 88.2% | |
| HF004 | 2014 | 9 | 11 | 81.8% | |
| HF004 | 2015 | 22 | 29 | 75.9% | |
| HF004 | 2016 | 20 | 24 | 83.3% | |
| HF004 | 2017 | 20 | 25 | 80.0% | |
| HF004 | 2018 | 18 | 25 | 72.0% | |
| HF004 | 2019 | 22 | 27 | 81.5% | |
| HF004 | 2020 | 24 | 27 | 88.9% | |
| HF006 | 2021 | 35 | 42 | 83.3% | |
| HF006 | 2022 | 46 | 48 | 95.8% | |
| HF006 | 2023 | 77 | 92 | 83.7% |
